In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Raman Sehgal for a special lookback episode on the topic of diversity in the life sciences space.
This week’s episode features excerpts from conversations with;
Barbara Morgan (Lubrizol at time of recording), now Global Vice President, Pharma and Biotechnology at Kerry discussing; gender diversity and the network of women supporting each other in their roles.
Tia Lyles-Williams, founder & CEO at LucasPye Bio discussing; the recent political climate and how that has affected steps forward in diversity and inclusion.
Jeff Dill, CEO at Vynamic discussing; the importance of diversity at his organization, and what they have put in place to ensure EDI goals are being achieved.
Andrew Moore, General Manager at Pfizer Center One discussing; his experience as a person of color in the sector, and how the conversation has changed in his time.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.